Anne Lesage
Founder bij PHARVARIS N.V.
Vermogen: 12 M $ op 31-03-2024
Profiel
Anne Lesage is the founder of GrayMatters Consulting BVBA (founded in 2010), Kosa Pharma GmbH (founded in 2013), Pharvaris NV (founded in 2015), and Pharvaris GmbH (founded in 2015).
She holds the title of Chief Early Development Officer at Pharvaris NV and Pharvaris GmbH.
Dr. Lesage earns a doctorate degree from Ghent University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PHARVARIS N.V.
0.93% | 01-04-2024 | 500 646 ( 0.93% ) | 12 M $ | 31-03-2024 |
Actieve functies van Anne Lesage
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARVARIS N.V. | Founder | 30-09-2015 |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Founder | 01-10-2015 |
Eerdere bekende functies van Anne Lesage
| Bedrijven | Functie | Einde |
|---|---|---|
| Kosa Pharma GmbH | Founder | - |
| GrayMatters Consulting BV | Founder | - |
Opleiding van Anne Lesage
| Ghent University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHARVARIS N.V. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| GrayMatters Consulting BV | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Health Technology |
| Kosa Pharma GmbH |
